- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
SANDU PHARMACEUTICALS has announced the closure of its trading window for company securities, effective January 1, 2026. This closure impacts directors, key management personnel, promoters, and designated persons. The window will reopen 48 hours after the declaration of the financial results for the quarter ended December 31, 2025. The company will announce the date for the board meeting to approve these results in due course. This standard procedure ensures fair trading practices before important financial updates are publicly released.